Discover the latest in health: evidence‑based wellness tips, medical breakthroughs, nutrition guidance, fitness insights, and expert advice for a healthier, happier life.
Hematology and Hemotherapy
–
‘Nature’
‘Nature’
In a phase I trial, the menin inhibitor revumenib achieves a complete response in 18 patients with AML, revealing a cause of resistance to this potential new treatment.